WEBINAR: Legal Insights into Peptide & Semaglutide Compounding: Navigating FDA, State Boards, and Telemedicine
| Overview / Abstract: |
Earn 1.0 hour (0.1 CEUs) of continuing education credit when you purchase the webinar, Legal Insights into Peptide & Semaglutide Compounding: Navigating FDA, State Boards, and Telemedicine. As peptide and semaglutide compounding continues to evolve, pharmacy professionals face new legal challenges and opportunities. This session will explain the latest updates and regulations in this area. Our expert speakers will discuss important topics like the FDA’s stance on peptide compounding, recent changes from state Boards of Pharmacy, and legal issues with brand manufacturers. The webinar will also explore the growing role of telemedicine and how it affects compounding, with tips on handling bulk chemical ingredients. Register now to stay updated, ensure compliance, and improve your practice while better supporting your patients. Click the following link to learn more and register: https://acainfo.org/peptidelaw/, or click "Access Activity" below. |
|
Expiration |
Feb 21, 2027 |
|
Discipline(s) |
Pharmacy CPE |
|
Format |
Online, Webinar / Webcast / Video |
|
Cost |
Members: $30 | Non-Members: $50 |
|
Credits / Hours |
1.0 |
|
Accreditation |
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this program for 1 contact hour (0.1 CEU) of continuing education credit for pharmacists and pharmacy technicians. |
|
Presenters / Authors / Faculty |
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA: Martha M. Rumore is a pharmacist-attorney with extensive experience in healthcare law, Food, Drug & Cosmetic law, pharmacy regulatory matters, PBM issues, and pharmaceutical and medical device intellectual property. She has over 15 years of law firm experience counseling clients on ANDA and 510(k) pathways and all aspects of Paragraph IV litigation. Matthew J. Modafferi, Esq: Matthew J. Modafferi is a litigation and trial attorney specializing in healthcare law, white collar defense, and complex civil litigation. A Partner in Frier Levitt’s Healthcare and Life Sciences Litigation Department, he represents clients in healthcare fraud, qui tam, and False Claims Act matters, as well as DEA and OIG investigations. He previously served as an Assistant U.S. Attorney in the Eastern District of New York, handling affirmative and defensive cases on behalf of the United States. |
|
Keywords / Search Terms |
American College of Apothecaries, Pharmacists, Pharmacy Technicians, Pharmacy, Compounding, Semaglutide, Semaglutide Compounding, Peptides, Pharmacy Law, Regulatory Issues, FDA Guidelines, State Board of Pharmacy Updates for Compounders, State Pharmacy Rules, Telemedicine/Telepharmacy, Best Practices, CE Session, Continuing Education, Webinar, Seminar |
|